A FOCUS ON ALK-POSITIVE NON-SMALL CELL LUNG CANCER
By
Michael Astrachan
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments. This animation takes an extensive and detailed look at the sub-populations of patients who have non-small cell lung cancer (NSCLC), which affects about 198,000 new patients in the United States each year. The animation …
GLUTAMATE MODULATION
By
Michael Astrachan
Glutamate is the most abundant excitatory neurotransmitter in the brain. Release of glutamate is essential for normal function of neurons, but the levels of this neurotransmitter must be tightly regulated to avoid toxic effects on neurons. XVIVO partnered with Biohaven to animate the glutamate story. The script details normal glutamate signaling, dysfunctional glutamate signaling and …
CHRONIC IDIOPATHIC CONSTIPATION
By
Michael Astrachan
These clips come from a project we developed that discuss the mechanisms of disease of Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome with Constipation (IBS-C). This medical animation depicts the micro-anatomy of the bowel from the level of bowel surface microvilli, down to the traffic of ions and proteins across specialized tight junctions that …
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments. This animation takes an extensive and detailed look at the sub-populations of patients who have non-small cell lung cancer (NSCLC), which affects about 198,000 new patients in the United States each year. The animation …
